APA (7th ed.) Citation

Pawar, V. A., Aradhya, A., Galvan, D., Borthakur, G., Iyer, S. P., Kirschbaum, M., . . . Vega, F. (2023). Preclinical Evaluation of T-Cell Prolymphocytic Leukemia Demonstrates Heterogeneous BCL2-Family Dependency That May be Effectively Targeted with Small Molecule Inhibitors. Blood, 142(Supplement 1), 4192. https://doi.org/10.1182/blood-2023-178256

Chicago Style (17th ed.) Citation

Pawar, Vishakha Anand, et al. "Preclinical Evaluation of T-Cell Prolymphocytic Leukemia Demonstrates Heterogeneous BCL2-Family Dependency That May Be Effectively Targeted with Small Molecule Inhibitors." Blood 142, no. Supplement 1 (2023): 4192. https://doi.org/10.1182/blood-2023-178256.

MLA (9th ed.) Citation

Pawar, Vishakha Anand, et al. "Preclinical Evaluation of T-Cell Prolymphocytic Leukemia Demonstrates Heterogeneous BCL2-Family Dependency That May Be Effectively Targeted with Small Molecule Inhibitors." Blood, vol. 142, no. Supplement 1, 2023, p. 4192, https://doi.org/10.1182/blood-2023-178256.